Rasko, N. B., Nahm, C. B., Turchini, J., Teh, R., Rasmussen, H., Byeon, S., . . . Mittal, A. FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival. Wiley.
Chicago Style (17th ed.) CitationRasko, Nathalie B., et al. FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival. Wiley.
MLA (9th ed.) CitationRasko, Nathalie B., et al. FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival. Wiley.
Warning: These citations may not always be 100% accurate.